TY - JOUR T1 - Functional connectivity of dorsolateral prefrontal cortex predicts cocaine relapse JF - medRxiv DO - 10.1101/2020.12.17.20245399 SP - 2020.12.17.20245399 AU - Tianye Zhai AU - Betty Jo Salmeron AU - Hong Gu AU - Bryon Adinoff AU - Elliot A. Stein AU - Yihong Yang Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/12/23/2020.12.17.20245399.abstract N2 - Background Relapse is one of the most perplexing problems of addiction. The dorsolateral prefrontal cortex (DLPFC) is crucially involved in numerous cognitive and affective processes that are implicated in phenotypes of addiction, and is one of the most frequently reported brain regions with aberrant functionality in substance use disorders. However, the DLPFC is an anatomically large and functionally heterogeneous region, and the specific DLPFC-based circuits that contribute to drug relapse remain unknown.Methods We systematically investigated the relationship of cocaine relapse with 98 DLPFC functional circuits defined by evenly sampling the entire bilateral DLPFC in a cohort of cocaine dependent patients (n=43, 5F) following a psychosocial treatment intervention. A Cox regression model was utilized to predict relapse likelihood based on DLPFC functional connectivity strength.Results Functional connectivity from 3 of the 98 DLPFC loci, one on the left and two on the right hemisphere, significantly predicted cocaine relapse with an accuracy of 83.9%, 84.7% and 85.4%, respectively. Combining all three significantly improved prediction validity to 87.5%. Protective and risk circuits related to these DLPFC loci were identified that are known to support “bottom up” drive to use drug and “top down” control over behavior together with social emotional, learning and memory processing.Conclusion Three DLPFC-centric circuits were identified that predict relapse to cocaine use with high accuracy. These functionally distinct DLPFC-based circuits provide insights into the multiple roles played by the DLPFC in cognitive and affective functioning that affects treatment outcome. The identified DLPFC loci may serve as potential neuromodulation targets for addiction treatment and as clinically relevant biomarkers of its efficacy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was supported by the Intramural Research Program of the National Institute on Drug Abuse (NIDA-IRP), NIH; NIDA Grant DA023203; and the University of Texas Southwestern Center for Translational Medicine UL1TR000451 (BA).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was reviewed and approved by the Institutional Review Boards of the University of Texas Southwestern Medical Center and the Veterans Administration North Texas Health Care System.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw data generated in the current study contain personally identifiable information that could compromise the privacy of research participants by sharing publicly. Derived data supporting the findings of this study are available from the corresponding author contingency of institutional approval, upon reasonable request.AbbreviationsACCanterior cingulate cortexAC-PCanterior commissure-posterior commissureAUCArea-Under-CurveAUDalcohol use disorderBOLDblood-oxygen-level-dependentCPDcigarette per dayCUDcocaine use disorderDLPFCdorsolateral prefrontal cortexDMNdefault mode networkDMPFCdorsomedial prefrontal cortexDSMthe Diagnostic and Statistical Manual of Mental DisordersECNexecutive control networkFFAfusiform face areafMRIfunctional MRIIFGinferior frontal gyrusIPLinferior parietal lobuleIQintelligence quotientMCLmesocorticolimbicMDDmajor depressive disorderMNIMontreal Neurological InstitutemPFCmedial prefrontal cortexMTLmedial temporal lobePCCposterior cingulate cortexROCreceiver operating characteristicROIregion-of-interestrTMSrepetitive TMSSDstandard deviationSUDsubstance use disordersTEecho timeTMStranscranial magnetic stimulationToMtheory of mindTRrepetition timeUDSurine drug screenVLPFCventrolateral prefrontal cortexvmOFCventromedial orbitofrontal cortexvmPFCventromedial prefrontal cortex ER -